PRDS DATA Tel: 185-1234-5678 页头:登录 | 页头:注册

GLENMARK LIFE SCIENCE LTD(NSE:GLS)

{{price.price}} INR
{{price.change}}%
{{price.high}} 130938 6.01% 34.49
{{price.low}} 141982620 31.44% 1335
{{price.open}} 0.57% 19.21% 676
{{price.close}} -0.16 8912370000% 133046185156
8.07 6.86 -2.49 27.37
9.4 44.26 44.58 44.58
3.61 4.75 4.04 130938
532497 1000771 符号详情:1天涨跌率 0.57 7.24
10.26 6 73 100
1076 1005 991 78977.5
109121.23 112640.53 169894.01 1.83
-0.16 -0.51 0.79 1.83
1.13 0.25 940 935
819 370 676 1095
1164 1335 1335 1335
38.43 34.56 4708880000 4235010000
2041510000 7403780000 8912370000 10
7.75 38.38 34.49 5506550000
22702150000 22048960000
2965450000
-4303150000 25384800000
4462920000 3015940000 4462920000 3015940000
20960580000 5226400000 4637340000 4637340000
159770000 30848590000 128743035156 29.88
20.74
19.21 32.61 40.42 21.07
17.18 27.32 24.97
Glenmark Life Sciences Ltd. engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

http://www.glenmarklifesciences.com

Yasir Rawjee

2011

Mumbai

Health technology

Pharmaceuticals: major